{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:12:45Z","timestamp":1781824365434,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["apjon.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Oncology Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.apjon.2025.100772","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:27:26Z","timestamp":1755012446000},"page":"100772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3452-0197","authenticated-orcid":false,"given":"Minjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9212-0099","authenticated-orcid":false,"given":"Yun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjon.2025.100772_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-t cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.apjon.2025.100772_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151628","article-title":"Advanced practice nursing and CAR-t cell therapy: opportunities, challenges and future directions","volume":"40","author":"Kisielewski","year":"2024","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.apjon.2025.100772_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"Hayden","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apjon.2025.100772_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1188\/21.CJON.255-258","article-title":"CAR t-cell therapy: updates in nursing management","volume":"25","author":"Baer","year":"2021","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.apjon.2025.100772_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105266","article-title":"Advancements and challenges in developing in vivo CAR t cell therapies for cancer treatment","volume":"106","author":"Bui","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apjon.2025.100772_bib6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR t cells and t-cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.apjon.2025.100772_bib7","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.21.01992","article-title":"Management of immune-related adverse events in patients treated with chimeric antigen receptor t-cell therapy: ASCO guideline","volume":"39","author":"Santomasso","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apjon.2025.100772_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s44228-022-00004-8","article-title":"The EBMT immune effector cell nursing guidelines on CAR-t therapy: a framework for patient care and managing common toxicities","volume":"4","author":"Ellard","year":"2022","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.apjon.2025.100772_bib9","first-page":"924","article-title":"Prolonged SARS-CoV-2 infection in a CAR t-cell therapy recipient","volume":"325","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.apjon.2025.100772_bib10","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.3390\/curroncol30050378","article-title":"Management and prevention of cellular-therapy-related toxicity: early and late complications","volume":"30","author":"Mucha","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.apjon.2025.100772_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jtct.2021.01.003","article-title":"Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor t cell therapy: a systematic review","volume":"27","author":"Kamal","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.apjon.2025.100772_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jtct.2023.01.004","article-title":"Multi-stakeholder qualitative interviews to inform measurement of patient reported outcomes after CAR-t","volume":"29","author":"Akinola","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.apjon.2025.100772_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4078","article-title":"Process mapping the patient journey: an introduction","volume":"341","author":"Trebble","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.apjon.2025.100772_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082265","article-title":"Patient experience factors and implications for improvement based on the treatment journey of patients with head and neck cancer","volume":"15","author":"Koo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apjon.2025.100772_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/s12913-021-06934-y","article-title":"Journey mapping as a novel approach to healthcare: a qualitative mixed methods study in palliative care","volume":"21","author":"Ly","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.apjon.2025.100772_bib16","article-title":"Constructivist grounded theory: characteristics and operational aspects for nursing research","volume":"55","author":"Metelski","year":"2021","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.apjon.2025.100772_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/eurjcn\/zvae012","article-title":"Patient journey mapping: emerging methods for understanding and improving patient experiences of health systems and services","volume":"23","author":"Bulto","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.apjon.2025.100772_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"10.1016\/j.apjon.2025.100772_bib19","doi-asserted-by":"crossref","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","article-title":"A simple method to assess and report thematic saturation in qualitative research","volume":"15","author":"Guest","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.apjon.2025.100772_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jan.15479","article-title":"Reporting and conducting patient journey mapping research in healthcare: a scoping review","volume":"79","author":"Davies","year":"2023","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.apjon.2025.100772_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4997\/jrcpe.2015.305","article-title":"Qualitative research in healthcare: an introduction to grounded theory using thematic analysis","volume":"45","author":"Chapman","year":"2015","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.apjon.2025.100772_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107074","article-title":"Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: longitudinal findings from the phase 2 KarMMa trial","volume":"129","author":"Delforge","year":"2023","journal-title":"Leuk Res"},{"key":"10.1016\/j.apjon.2025.100772_bib23","first-page":"303","article-title":"Patients' experience with chimeric antigen receptor t-cell therapy for DLBCL in China: a qualitative study","volume":"31","author":"Mao","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.apjon.2025.100772_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/cncr.34557","article-title":"Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor t-cell therapy","volume":"129","author":"Dhawale","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.apjon.2025.100772_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/02692163221138880","article-title":"A qualitative service evaluation of patient and caregiver experiences of CAR-t therapy: recommendations for service development and implications for palliative care teams","volume":"37","author":"Stenson","year":"2023","journal-title":"Palliat Med"},{"key":"10.1016\/j.apjon.2025.100772_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152431","article-title":"The influence of psychological traits and prior experience on treatment expectations","volume":"127","author":"Basedow","year":"2023","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.apjon.2025.100772_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40487-023-00232-9","article-title":"Patient perceptions of CAR-t therapy in the USA: findings from in-depth interviews","volume":"11","author":"Bixby","year":"2023","journal-title":"Oncol Ther"}],"container-title":["Asia-Pacific Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562525001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562525001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:41:17Z","timestamp":1766439677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2347562525001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S2347562525001209"],"URL":"https:\/\/doi.org\/10.1016\/j.apjon.2025.100772","relation":{},"ISSN":["2347-5625"],"issn-type":[{"value":"2347-5625","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjon.2025.100772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Asian Oncology Nursing Society.","name":"copyright","label":"Copyright"}],"article-number":"100772"}}